NP
CL icon

NorthRock Partners’s Colgate-Palmolive CL Stock Holding History

NorthRock Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$720K Buy
8,450
+62
+0.7% +$5.53K 0.01% 359
2025
Q4 		$663K Sell
8,388
-6,894
-45% -$541K 0.01% 328
2025
Q3 		$1.22M Buy
15,282
+5,899
+63% +$503K 0.02% 303
2025
Q2 		$853K Buy
9,383
+974
+12% +$88.9K 0.02% 275
2025
Q1 		$788K Hold
8,409
– – 0.03% 246
2024
Q4 		$764K Sell
8,409
-224
-3% -$21.4K 0.02% 252
2024
Q3 		$896K Buy
8,633
+186
+2% +$19K 0.03% 228
2024
Q2 		$820K Buy
8,447
+1,251
+17% +$115K 0.03% 228
2024
Q1 		$648K Buy
7,196
+470
+7% +$39.8K 0.02% 289
2023
Q4 		$536K Buy
+6,726
New +$506K 0.02% 307
2023
Q3 		– Sell
-2,714
Closed -$209K – 358
2023
Q2 		$209K Sell
2,714
-110
-4% -$8.52K 0.02% 286
2023
Q1 		$212K Buy
2,824
+128
+5% +$9.52K 0.02% 299
2022
Q4 		$212K Sell
2,696
-767
-22% -$57.5K 0.02% 317
2022
Q3 		$243K Sell
3,463
-681
-16% -$53.4K 0.03% 252
2022
Q2 		$332K Buy
4,144
+668
+19% +$52.2K 0.03% 202
2022
Q1 		$264K Buy
3,476
+595
+21% +$47.1K 0.02% 266
2021
Q4 		$246K Buy
+2,881
New +$225K 0.02% 278
2021
Q3 		– Sell
-3,893
Closed -$317K – 285
2021
Q2 		$317K Buy
3,893
+327
+9% +$26.7K 0.03% 188
2021
Q1 		$281K Buy
3,566
+27
+0.8% +$2.12K 0.03% 182
2020
Q4 		$303K Hold
3,539
– – 0.03% 174
2020
Q3 		$273K Buy
3,539
+4
+0.1% +$305 0.03% 176
2020
Q2 		$259K Sell
3,535
-227
-6% -$16.1K 0.03% 172
2020
Q1 		$250K Sell
3,762
-741
-16% -$52.3K 0.04% 159
2019
Q4 		$310K Buy
4,503
+402
+10% +$27.4K 0.03% 209
2019
Q3 		$301K Buy
+4,101
New +$298K 0.04% 167
2015
Q2 		– Sell
-2,888
Closed -$200K – 49
2015
Q1 		$200K Hold
2,888
– – 0.12% 42
2014
Q4 		$200K Buy
+2,888
New +$195K 0.12% 42

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NorthRock Partners's CL Position: Q1 2026 in Review

NorthRock Partners increased its Colgate-Palmolive (CL) stake by 0.74% in Q1 2026, buying an estimated $5.53K and bringing the position to 8,450 shares worth $720K. The position accounts for 0.01% of the portfolio, ranked #359.

NorthRock Partners first reported a position in CL in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.22M in Q3 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • NorthRock Partners held 8,450 shares of Colgate-Palmolive worth $720K as of Q1 2026.
  • NorthRock Partners bought 62 Colgate-Palmolive shares in Q1 2026, an estimated $5.53K.
  • Colgate-Palmolive made up 0.01% of NorthRock Partners's portfolio in Q1 2026, its #359 holding.
  • NorthRock Partners first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 27 quarters since.
  • NorthRock Partners's Colgate-Palmolive position peaked at $1.22M in Q3 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.